Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Capital Expenditures (2016 - 2018)

Armata Pharmaceuticals' Capital Expenditures history spans 6 years, with the latest figure at $391000.0 for Q4 2018.

  • For Q4 2018, Capital Expenditures rose 2072.22% year-over-year to $391000.0; the TTM value through Dec 2018 reached $597000.0, up 929.31%, while the annual FY2024 figure was $1.9 million, 76.93% down from the prior year.
  • Capital Expenditures for Q4 2018 was $391000.0 at Armata Pharmaceuticals, up from $155000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $831000.0 in Q2 2014 and bottomed at $2000.0 in Q2 2017.
  • The 5-year median for Capital Expenditures is $35000.0 (2015), against an average of $141333.3.
  • The largest annual shift saw Capital Expenditures plummeted 98.4% in 2017 before it skyrocketed 2072.22% in 2018.
  • A 5-year view of Capital Expenditures shows it stood at $5000.0 in 2014, then skyrocketed by 600.0% to $35000.0 in 2015, then tumbled by 62.86% to $13000.0 in 2016, then skyrocketed by 38.46% to $18000.0 in 2017, then surged by 2072.22% to $391000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Capital Expenditures are $391000.0 (Q4 2018), $155000.0 (Q3 2018), and $18000.0 (Q4 2017).